Procalcitonin in Cirrhotic Patients at High Risk for Sepsis
NCT01578226
Ascites, Bacterial Infections
Modena, Italy
View Trial DetailsNCT Number: NCT07465003
Study population: Patients with liver cirrhosis complicated by sepsis Observation indicators: Fluid resuscitation strategy, early dynamic indicators such as MAP Observation endpoint: 28-day all-cause mortality Study design: Retrospective cohort study
Trial opening soon.
Get NotifiedAll sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline and 28 days.
Trial opening soon.
Get NotifiedThe Second Affiliated Hospital of Chongqing Medical University
Other
Use of Antimicrobial Drugs in Severe Infections and Epidemiological Study of Populations With Severe Infections
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01578226
Ascites, Bacterial Infections
Modena, Italy
View Trial DetailsNCT00124228
Cirrhosis, Female Urogenital Diseases
Barcelona, Spain
View Trial DetailsNCT07820917
Behavior, Behavioral Symptoms
Ann Arbor, Michigan, United States
View Trial DetailsNCT07652203
Cirrhosis, Fibrosis
Shenyang, Liaoning, China
View Trial Details